Kushima Hisako, Tokimatsu Issei, Ishii Hiroshi, Kawano Rie, Watanabe Kentaro, Kadota Jun-Ichi
Department of Respiratory Medicine, Fukuoka University Hospital.
Med Mycol J. 2017;58(1):E23-E28. doi: 10.3314/mmj.16-00027.
The mechanisms of azole resistance in Trichosporon asahii have not yet been fully clarified. We previously showed that T. asahii has the ERG11 gene, coding lanosterol 14-α-demethylase (Erg11 protein; Erg11p), which is the primary target of azoles. A single amino acid substitution at G453R in Erg11p was found to induce changes in the affinity of this enzyme for azoles, especially fluconazole, in vitro. In the present study, we investigated the DNA sequences of the ERG11 gene using six different strains of clinically isolated T. asahii that were highly resistant to multi-azoles, including fluconazole, itraconazole, and voriconazole. All of the T. asahii strains had a point mutation (G448A) that caused a single amino acid substitution at G150S in Erg11p. This amino acid is highly conserved among major fungal pathogens. We identified a new point mutation in the ERG11 gene that is common to clinically isolated azole-resistant T. asahii strains, suggesting that this mutation is associated with the multi-azole resistance of T. asahii.
浅白隐球酵母对唑类药物耐药的机制尚未完全阐明。我们之前发现浅白隐球酵母拥有ERG11基因,该基因编码羊毛甾醇14-α-去甲基酶(Erg11蛋白;Erg11p),而此酶是唑类药物的主要作用靶点。体外实验发现,Erg11p中G453R位点的单个氨基酸替换会导致该酶对唑类药物,尤其是氟康唑的亲和力发生变化。在本研究中,我们使用了六株临床分离的对多种唑类药物(包括氟康唑、伊曲康唑和伏立康唑)高度耐药的浅白隐球酵母菌株,对ERG11基因的DNA序列进行了研究。所有浅白隐球酵母菌株均存在一个点突变(G448A),该突变导致Erg11p中G150S位点的单个氨基酸替换。这个氨基酸在主要真菌病原体中高度保守。我们在ERG11基因中鉴定出一个新的点突变,该突变在临床分离的对唑类药物耐药的浅白隐球酵母菌株中普遍存在,这表明该突变与浅白隐球酵母对多种唑类药物的耐药性有关。